Clinical Trial Update: Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating combination chemotherapy, PEG-interferon alfa-2b, and surgery for localized and metastatic osteosarcoma has completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• Combination chemotherapy
• PEG-Interferon alfa-2b (pegylated interferon alfa-2b)
• Surgery

Snippet

Sponsor: Children's Oncology Group | Conditions: Localized Osteosarcoma, Metastatic Osteosarcoma | Phase 3 | Status: COMPLETED | Results posted: 2023-06-07